LIVE
Week of Mar 14, 2026

Active M&A Deals

Showing 3 of 10 tracked deals. Subscribe for full access

Active Deals
10
Avg Spread
4.79%
Avg Ann. Return
16.3%
Low Risk Deals
4
#1AbbVie → Aliada TherapeuticsHigh
Biotech
Deal Value
$1.4B
Current / Offer
$24.60 / $26.00
Spread
5.69%
Ann. Return
34.2%
Expected Close
Apr 30, 2026(0d)
Type
Cash
Phase 2 data readout could affect deal; antitrust low-risk
#2Qualcomm → Alphawave SemiHigh
Semiconductors
Deal Value
$4.9B
Current / Offer
$4.82 / $5.15
Spread
6.85%
Ann. Return
22.8%
Expected Close
Jun 30, 2026(0d)
Type
Cash
CFIUS national security review ongoing
#3Diamondback Energy → Endeavor EnergyMedium
Energy
Deal Value
$26.0B
Current / Offer
$52.10 / $55.00
Spread
5.57%
Ann. Return
18.6%
Expected Close
Jun 15, 2026(0d)
Type
Cash & Stock
State regulatory approvals pending; shareholder approved
ConocoPhillips → Marathon OilLow
$22.5B
$28.40 / $29.75
4.75%
15.8%
May 30, 2026
Stock
Hewlett Packard Enterprise → Juniper NetworksHigh
$14.0B
$37.85 / $40.00
5.68%
15.6%
Aug 31, 2026
Cash
Mars Inc. → KellanovaLow
$35.9B
$79.20 / $83.50
5.43%
14.9%
Jul 31, 2026
Cash
Brookfield → Tritax Big Box REITMedium
$6.2B
$152.30 / $160.00
5.06%
11.3%
Aug 15, 2026
Cash
Synopsys → AnsysMedium
$35.0B
$244.80 / $253.00
3.35%
11.2%
Jun 30, 2026
Cash & Stock
Johnson & Johnson → Intra-Cellular TherapiesLow
$14.6B
$128.90 / $132.00
2.41%
9.8%
May 31, 2026
Cash
Capital One → Discover FinancialLow
$35.3B
$178.52 / $184.00
3.07%
8.4%
May 15, 2026
Stock
+7 more deals
Subscribe to unlock the full monitor
Unlock All Deals — $29/mo

Disclaimer: Arbitrack provides informational data only. Nothing on this site constitutes financial advice. Merger arbitrage carries risk including potential loss of principal. Always do your own research.